Skip to main content
OpenTrials

Clinical trial condition

Hepatocellular Carcinoma (HCC)

Explore clinical trials studying Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.

230 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Hepatocellular Carcinoma (HCC) trial results

Active, Not Recruiting

A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation

NCT04639180

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Guangxi Medical University Affiliated Tumor Hospital Nanjin, Guangzhou, China
  • Guizhou Cancer Hospital Guiyang, Guizhou, China
  • Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Active, Not Recruiting

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

NCT06521567

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +56 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Iowa City, Iowa, United States
  • GSK Investigational Site Hackensack, New Jersey, United States
  • GSK Investigational Site Cincinnati, Ohio, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma

NCT05022927

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Chiba University Hospital Chiba, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Kanagawa Cancer Center Yokohama, Kanagawa, Japan
  • Kindai University Hospital Sayama, Osaka, Japan
View Trial Details

Related conditions